(19)
(11) EP 1 150 670 A2

(12)

(88) Date of publication A3:
05.04.2001

(43) Date of publication:
07.11.2001 Bulletin 2001/45

(21) Application number: 00914574.9

(22) Date of filing: 10.02.2000
(51) International Patent Classification (IPC)7A61K 31/195, A61K 31/19, A61K 31/175, A61K 31/255, A61K 45/06, A61K 31/335, A61K 31/165, A61K 31/275, A61K 31/57, A61P 9/00, A61P 35/00
(86) International application number:
PCT/US0003/667
(87) International publication number:
WO 0047/197 (17.08.2000 Gazette 2000/33)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 12.02.1999 US 119951 P

(71) Applicant: Quanam Medical Corporation
Santa Clara, CA 95050 (US)

(72) Inventors:
  • ALVARADO, Angelica
    Santa Clara, CA 95051 (US)
  • EURY, Robert
    Cupertino, CA 95014 (US)
  • POMERANTSEVA, Irina, D.
    Mountain View, CA 94041 (US)
  • FROIX, Michael
    Mountain View, CA 94040 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) ALKYLATING AGENTS FOR TREATMENT OF CELLULAR PROLIFERATION